DX2Z:F:F-Xtrackers - S&P Select Frontier Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 19.142

Change

+0.20 (+1.03)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.52 (+0.28%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.96 (+1.93%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.14 (+2.08%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.30 (+1.98%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

+0.54 (+0.56%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.80 (+1.68%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

+0.03 (+0.36%)

USD 41.48B
0ZC:F Zscaler Inc

-2.50 (-1.36%)

USD 37.92B
BSND:F Danone SA

-0.30 (-2.13%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing DX2Z:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.70% 30% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.70% 30% F 43% F
Trailing 12 Months  
Capital Gain 20.13% 88% B+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.13% 85% B 66% D+
Trailing 5 Years  
Capital Gain 105.56% 76% C+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 105.56% 76% C+ 55% F
Average Annual (5 Year Horizon)  
Capital Gain 15.12% 84% B 73% C
Dividend Return 15.12% 82% B 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.60% 30% F 74% C
Risk Adjusted Return 85.89% 83% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.